NCT04757077

Brief Summary

Background: Pregnancy-related pelvic girdle pain (PGP) can appear during pregnancy, directly after labour or can be delayed to 3 weeks postpartum. Pain is experienced between the posterior iliac crest and the gluteal fold, particularly in the vicinity of the sacroiliac joint (SIJ). The pain may radiate in the posterior thigh and can also occur in conjunction with/or separately in the symphysis. The endurance capacity for standing, walking, and sitting is diminished. The diagnosis of PGP can be reached after exclusion of lumbar causes. The pain or functional disturbances in relation to PGP must be reproducible by specific clinical tests. Lack of accurate and early diagnosis of the PGP postpartum may contribute to development of chronic condition, lowering quality of life years after delivery. There is uncertainty regarding the association between the function of the pelvic floor muscles (PFM), diastasis recti and postpartum pelvic girdle pain (PGP). Although widely researched abroad, there is a paucity in research about biopsychosocial profile of women with postpartum PGP in Poland. Objectives: The aim of this one-to-one matched case-control study it to examine whether there is any difference in PFM function and diastasis recti between women with and without clinically diagnosed PGP. Additionally, differences in biopsychosocial profile (depression, anxiety, stress, catastrophizing and kinesiophobia) will be assessed. Materials and methods: Because of low incidence of researched condition, a case control study will be the study design of choice. Women 6-24 weeks after delivery with postpartum PGP will be matched with those with no PGP. Subjects' assessment will consist of palpation examination of diastasis recti (inter-recti distance) and pelvic floor muscles. Perineometry of the pelvic floor will also be conducted. Additionally, several questionnaires for the assessment of mental processing will be used: Depression Anxiety Stress Scale 21, Pain Catastrophizing Scale and Tampa Scale of Kinesiophobia. Participants will be matched according to age, parity and time postpartum. Expected results: To our knowledge, postpartum pelvic girdle pain has not been extensively studied in Poland so far. The study will bring information about the possible associations with postpartum PGP. We hypothesize that the study will confirm our clinical observations about pelvic floor dysfunction and maladaptive mental processing in women with postpartum PGP.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
56

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Feb 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 15, 2021

Completed
1 day until next milestone

First Posted

Study publicly available on registry

February 16, 2021

Completed
6 days until next milestone

Study Start

First participant enrolled

February 22, 2021

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2021

Completed
Last Updated

July 14, 2021

Status Verified

April 1, 2021

Enrollment Period

3 months

First QC Date

February 15, 2021

Last Update Submit

July 13, 2021

Conditions

Outcome Measures

Primary Outcomes (3)

  • Perineometry of the pelvic floor - vaginal resting pressure.

    Measurement of the vaginal resting pressure.

    one time assessment, 6-24 weeks after delivery

  • Perineometry of the pelvic floor - vaginal squeeze pressure.

    Measurement of the vaginal squeeze pressure.

    one time assessment, 6-24 weeks after delivery

  • Palpable measurement of inter-recti distance (IRD)

    Palpable measurement of inter-recti distance (IRD)

    one time assessment, 6-24 weeks after delivery

Secondary Outcomes (5)

  • Perineometry of the pelvic floor - endurance

    one time assessment, 6-24 weeks after delivery

  • Diastasis Recti: palpation examination of the stability of the linea alba

    one time assessment, 6-24 weeks after delivery

  • Palpation examination of pelvic floor muscles with the use of PERFECT Scheme

    one time assessment, 6-24 weeks after delivery

  • Pain Catastrophizing Scale

    one time assessment, 6-24 weeks after delivery

  • Depression Anxiety Stress Scale 21

    one time assessment, 6-24 weeks after delivery

Study Arms (2)

GROUP 1

Patients 6-24 weeks after delivery with postpartum PGP (Patients with symptoms and signs of PGP, PGP confirmed with dedicated functional tests).

GROUP 2

Patients 6-24 weeks after delivery, with no symptoms and signs of PGP.

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Women, 6-24 weeks after delivery

You may qualify if:

  • Vaginal labour (including vacuum extractor or forceps) or caesarean section
  • For group with PGP: pain due to PGP
  • For control group with no pain - no pain due to PGP
  • Agreement to participate

You may not qualify if:

  • Diseases that can mimic PGP f.ex. Scheuermann disease, rheumatoid arthritis, Ehler's-Danlos Syndrome, hip dysplasia.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St. Sophia's Specialist Hospital

Warsaw, 01-004, Poland

Location

MeSH Terms

Conditions

Pelvic Girdle PainDiastasis Recti And Weakness Of The Linea AlbaPelvic Floor Disorders

Condition Hierarchy (Ancestors)

Musculoskeletal PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsPelvic PainFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesPregnancy ComplicationsMale Urogenital Diseases

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 15, 2021

First Posted

February 16, 2021

Study Start

February 22, 2021

Primary Completion

May 31, 2021

Study Completion

May 31, 2021

Last Updated

July 14, 2021

Record last verified: 2021-04

Locations